Acasă › Neoplazii mieloproliferative › Alabama
Studii clinice pentru Neoplazii mieloproliferative în Alabama
8 studii pentru Neoplazii mieloproliferative caută participanți în Alabama.
Orașe în Alabama
Text oficial al studiului (în engleză)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Alabama at Birmingham Cancer Center, Birmingham
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT05564390Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- University of Alabama at Birmingham Cancer Center, Birmingham
În curs de recrutareFaza 2
Vârste de la 18 la 59 · Toate sexele · Actualizat 22 sept. 2026 · NCT05554406Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
În curs de recrutareStudiu observațional
Până la vârsta de 25 · Toate sexele · Actualizat 25 aug. 2026 · NCT02402244Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- University of Alabama At Birmingham, Birmingham
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 iul. 2026 · NCT07441694A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Alabama Birmingham, Birmingham
În curs de recrutareFaza 2
Vârste de la 18 la 66 · Toate sexele · Actualizat 17 mar. 2026 · NCT06859424SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 28 oct. 2025 · NCT03452774Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
- University of Alabama at Birmingham, Birmingham
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 8 oct. 2025 · NCT06265584Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
- University of Alabama at Birmingham, Birmingham
În curs de recrutareFaza 2
Vârste de la 18 la 60 · Toate sexele · Actualizat 8 oct. 2025 · NCT06315309Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.